Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies (Q78773743)

From Wikidata
Jump to navigation Jump to search
scientific article published on 09 January 2003
edit
Language Label Description Also known as
English
Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies
scientific article published on 09 January 2003

    Statements

    Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit